This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: Han Bio USA, Hanbio Co., Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations in Stem Cell Technology by Hyunchul Kang
Introduction
Hyunchul Kang is an innovative inventor based in Bucheon, South Korea. He has made significant contributions to the field of tissue engineering, particularly through his work on stem cell culture technologies. His research focuses on developing methods that enhance the viability and functionality of human organoids.
Latest Patents
Hyunchul Kang holds a patent for a "Method for producing stem cell culture plate available for tissue engineering using 3D printing for human organoid generation." This method involves feeding filament-shaped biodegradable polymer materials, which are non-toxic to the human body, into a 3D printer. The process includes producing a cell culture plate that can culture cells in a desired shape while ensuring excellent biocompatibility. This innovation allows for direct application in vivo without detaching cells from the plate, marking a significant advancement in the field.
Career Highlights
Throughout his career, Hyunchul Kang has worked with notable companies such as Han Bio USA and Hanbio Co., Ltd. His experience in these organizations has contributed to his expertise in developing cutting-edge technologies in the biomedical field.
Collaborations
Hyunchul has collaborated with talented individuals in his field, including Chaeyeon Kim and Jeongwon Rho. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Hyunchul Kang's work in developing a method for producing stem cell culture plates using 3D printing represents a significant leap forward in tissue engineering. His contributions are paving the way for future advancements in organoid generation and regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile